[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=0094f906ca06bfcc857ddb57b29bc868a5013f2f1339f229c3667dc54ede9e8f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750783620,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 135548280,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=0094f906ca06bfcc857ddb57b29bc868a5013f2f1339f229c3667dc54ede9e8f"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron: Potential Entrant To Weight Loss Market",
    "summary": "Regeneron shows financial strength and fair valuation, but trevogrumab's Phase 2 progress adds uncertainty. Click here to read an analysis of REGN stock now.",
    "url": "https://finnhub.io/api/news?id=3024dbb12ca1490d3a031e0f2a34515d5cd9b0b8f88980b21fd7792ef6bb339d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750774431,
      "headline": "Regeneron: Potential Entrant To Weight Loss Market",
      "id": 135508972,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/470752276/image_470752276.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Regeneron shows financial strength and fair valuation, but trevogrumab's Phase 2 progress adds uncertainty. Click here to read an analysis of REGN stock now.",
      "url": "https://finnhub.io/api/news?id=3024dbb12ca1490d3a031e0f2a34515d5cd9b0b8f88980b21fd7792ef6bb339d"
    }
  },
  {
    "ts": null,
    "headline": "Sanofi Trades Below 50 & 200-Day Moving Averages: Time to Buy the Dip?",
    "summary": "SNY trades below key moving averages but strong Dupixent growth, pipeline wins and rising estimates may keep bulls invested.",
    "url": "https://finnhub.io/api/news?id=4f1814c61898f002612a3f6e6c7351d3491b9154d4a45ccd53d735bc987373e0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750773360,
      "headline": "Sanofi Trades Below 50 & 200-Day Moving Averages: Time to Buy the Dip?",
      "id": 135506743,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "SNY trades below key moving averages but strong Dupixent growth, pipeline wins and rising estimates may keep bulls invested.",
      "url": "https://finnhub.io/api/news?id=4f1814c61898f002612a3f6e6c7351d3491b9154d4a45ccd53d735bc987373e0"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization",
    "summary": "Initiative aims to expand and encourage philanthropy to help patients with retinal diseases afford their medicationsTARRYTOWN, N.Y., June 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the launch of a pioneering matching program for donations to Good Days, an independent national non-profit charitable organization, to support Good Days’ Retinal Vascular and Neovascular Disease Fund. Through this initiative, Regeneron has committed to matching donation",
    "url": "https://finnhub.io/api/news?id=685ccf5b4a3517304ee8ae2527739e06370dd744e454ff6d7e93bfb7df8bec43",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750764600,
      "headline": "Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization",
      "id": 135497278,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Initiative aims to expand and encourage philanthropy to help patients with retinal diseases afford their medicationsTARRYTOWN, N.Y., June 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the launch of a pioneering matching program for donations to Good Days, an independent national non-profit charitable organization, to support Good Days’ Retinal Vascular and Neovascular Disease Fund. Through this initiative, Regeneron has committed to matching donation",
      "url": "https://finnhub.io/api/news?id=685ccf5b4a3517304ee8ae2527739e06370dd744e454ff6d7e93bfb7df8bec43"
    }
  }
]